Provisions within the Health and Care Act 2022 come into force on 30 August 2022. Therefore, the Approval of a Class of Place for Treatment for the Termination of Pregnancy (Wales) 2022 is revoked to ensure there is no overlap in legislation.
These Directions make amendments to the Pharmaceutical Services (Advanced and Enhanced Services) (Wales) Directions 2005, which came into force on 5 May 2005, as regards the medicines use review and the discharge medicines review service.
These Directions which are given to Local Health Boards in Wales make provision for the advanced services of stoma appliance customisation and appliance use reviews in relation to the dispensing of stoma and urology appliances.
During 2006/7 the Pharmaceutical Services Negotiating Committee conducted a review of the NHS MUR form. The aim of the review was to streamline the form to make it more user friendly for pharmacists, GP's and their patients.
Requiring LHBs and NHS Trusts in Wales to provide medicines recommended by NICE within two months of the of publication of the Final Appraisal Determination and to provide medicines recommended by the All Wales Medicines Strategy Group and endorsed by the Welsh Ministers within two months of the endorsement.